Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 12

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 12
---
 which made consequential amendments to the existing
Articles of Association of the Company to reflect the November Subdivision. As is standard for deferred shares, each C deferred share
has very limited rights and is effectively valueless. The C deferred shares have the rights and restrictions as set out in the Articles
of Association and do not entitle the holder thereof to receive notice of or attend and vote at any general meeting of the Company or
to receive a dividend or other distribution.

On June 11, 2025, we held
a general meeting of shareholders, or June 2025 GM, and our shareholders passed resolutions to (i) subdivide our Ordinary Shares of £0.00005
nominal value each into one ordinary share of £0.000001 nominal value and 49 D deferred shares of £0.000001 nominal value
each, each the June 2025 Subdivision, and (y) adopt new Articles of Association, which made consequential amendments to the existing Articles
of Association of the Company to reflect the June Subdivision. As is standard for deferred shares, each D deferred share has very limited
rights and is effectively valueless. The D deferred shares have the rights and restrictions as set out in the Articles of Association
and do not entitle the holder thereof to receive notice of or attend and vote at any general meeting of the Company or to receive a dividend
or other distribution.

| 2 |

On July 31, 2025, we effected
a ratio change in the number of Ordinary Shares represented by our Depositary Shares from 10,000 Ordinary Shares per Depositary Share
to 100,000 Ordinary Shares per Depositary Share. No fractional Depositary Shares were issued.

The change in the number of
Ordinary Shares resulting from the reverse stock split and change in the number of Depositary Shares (and the underlying Ordinary Shares)
resulting from the change in ratio, including any changes resulting from fractional Depositary Shares not being issued to holders in connection
with the Depositary Share ratio change, has been applied retroactively to all share and per share amounts presented in this prospectus,
to the extent applicable. As a result of retroactively applying changes resulting from fractional Depositary Shares not being issued to
holders in connection with the Depositary Share ratio change, the amount of Ordinary Shares issued in prior transactions may not equal
the amount of Depositary Shares such Depositary Shares are currently exercisable for.

| 3 |

<div align='center'>MARKET AND INDUSTRY